Challenges of Estimates in Drug-Related Overdose Deaths in Iran: Evidence from the Literature
Abstract
No Abstract
Khosravi A, Aghamohamadi S, Kazemi E, Pourmalek F, Shariati M. Mortality Profile in Iran (29 provinces) over the years 2006 to 2010. Tehran: Ministry of Health and Medical Education; 2013. pp:7-21.
Sheidaei A, Gohari K, Kasaeian A, Rezaei N, Mansouri A, Khosravi A, et al. National and Subnational Patterns of Cause of Death in Iran 1990-2015: Applied methods. Arch Iran Med. 2017;20(1):2-11.
Rostami M, Karamouzian M, Khosravi A, Rezaeian S. Gender and geographical inequalities in fatal drug overdose in Iran: A province-level study in 2006 and 2011. Spat Spatiotemporal Epidemiol. 2018;25:19-24.
Rostami M, Mohammadi Y, Jalilian A, Nazparvar B. Modeling spatio-temporal variations of substance abuse mortality in Iran using a log-Gaussian Cox point process. Spat Spatiotemporal Epidemiol. 2017;22:15-25.
Amin-Esmaeili M, Rahimi-Movaghar A, Sharifi V, Hajebi A, Radgoodarzi R, Mojtabai R, et al. Epidemiology of illicit drug use disorders in Iran: prevalence, correlates, comorbidity and service utilization results from the Iranian Mental Health Survey. Addiction. 2016;111(10):1836-47.
Naghavi M, Shahraz S, Sepanlou SG, Dicker D, Naghavi P, Pourmalek F, et al. Health transition in Iran toward chronic diseases based on results of Global Burden of Disease 2010. Arch Iran Med. 2014;17(5):321-35.
Khosravi A, Taylor R, Naghavi M, Lopez AD. Differential mortality in Iran. Popul Health Metr. 2007;5:7. doi: 10.1186/478-7954-5-7.
Livingston JD, Milne T, Fang ML, Amari E. The effectiveness of interventions for reducing stigma related to substance use disorders: a systematic review. Addiction. 2011;107:39-50.
| Files | ||
| Issue | Vol 49 No 8 (2020) | |
| Section | Letter to the Editor | |
| DOI | https://doi.org/10.18502/ijph.v49i8.3914 | |
| PMCID | PMC7554398 | |
| PMID | 33083345 | |
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
